Brendan Bulik-Sullivan
InvestorFounderGeneral Partner at GV (Google Ventures) · Board director at Comanche Biopharma · Board director at Ventus Therapeutics
San Francisco, California
Writes $250K – $50M checks · typically $25M
About
General partner at GV focused on life sciences investments, interested in therapeutic biotechnology and diagnostics across all stages. Before GV, he worked on applied statistics and machine learning in genetics and biotech at Gritstone Oncology and the Broad Institute, with published research in Nature and Science. He holds a B.A. in mathematics from UC Berkeley and a Ph.D. in statistical genetics from Vrije Universiteit Amsterdam.
Invests in
AI & Machine LearningBiotech
Beyond investing
- Education
- Studied at University of California, Berkeley (B.A., Mathematics) Studied at Vrije Universiteit Amsterdam (PhD, Statistical Genetics)
- More
- Bulik-Sullivan developed the LD Score Regression method for statistical genetics, resulting in publications in Nature and Science.
From Brendan's own website — common ground for a warm intro.
Board director at Comanche Biopharma
Intro paths
→
In turn, Brendan can intro founders to Comanche Biopharma's investors below.
Comanche Biopharma's investors · 6
Atlas VentureCambridge · $500K – $1M checks · since 2024Broadview VenturesBostonF-Prime CapitalCambridge · $3M – $10M checks · since 2024GV (Google Ventures)Mountain View · $250K – $50M checks · since 2024Lilly Asia VenturesHong Kong · since 2024New Enterprise Associates (NEA)Menlo Park · $200K – $40M checks · since 2024
Co-founders at Comanche Biopharma
TS
T Scott JohnsonFounder
MY
Mike YoungFounder
Board director at Ventus Therapeutics
Intro paths
→
In turn, Brendan can intro founders to Ventus Therapeutics's investors below.
Ventus Therapeutics's investors · 5
Co-founders at Ventus Therapeutics
JL
Judith LiebermanCo-Founder, MD, PhD
Experience
- GVGeneral Partnercurrent2019 — presentSan Francisco, California, United States
Education
- University of California, BerkeleyBachelor of Arts (B.A.), Mathematics
- Vrije Universiteit Amsterdam (VU Amsterdam)Doctor of Philosophy (PhD), Statistical Genetics
Investments
Board seats
Per curated public sources.
Colleagues at GV (Google Ventures)
Andrew Wheeler
General Partner at GV (Google Ventures)
Anika Gupta
Investor at GV (Google Ventures)
Anika Gupta Vatsa
Principal at GV (Google Ventures)
Anthony Philippakis
Investor at GV (Google Ventures)
Ben Robbins
Investor at GV (Google Ventures)
Braden Kowitz
Investor at GV (Google Ventures)
Bradley Horowitz
Investor at Wisdom Ventures
Brian Bendett
Partner at GV (Google Ventures)
Network10
David KraneScout
CEO & Managing Partner at GV (Google Ventures)
Erik NordlanderScout
Investor at GV (Google Ventures)
Graham SpencerScout
General Partner at GV (Google Ventures)
Lo ToneyScout
Founding Managing Partner at Plexo Capital
M.G. SieglerScout
General Partner at GV (Google Ventures)
Andrew Wheeler
General Partner at GV (Google Ventures)
Anika Gupta
Investor at GV (Google Ventures)
Ben Robbins
Investor at GV (Google Ventures)
Braden Kowitz
Investor at GV (Google Ventures)
Christine Borowski
Vice President at Access Biotechnology
Investors connected to Brendan in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Brendan Bulik-Sullivan?
- General partner at GV focused on life sciences investments, interested in therapeutic biotechnology and diagnostics across all stages. Before GV, he worked on applied statistics and machine learning in genetics and biotech at Gritstone Oncology and the Broad Institute, with published research in Nature and Science. He holds a B.A. in mathematics from UC Berkeley and a Ph.D. in statistical genetics from Vrije Universiteit Amsterdam.
- Where does Brendan Bulik-Sullivan work?
- Brendan Bulik-Sullivan is General Partner at GV (Google Ventures) and Board director at Comanche Biopharma and Board director at Ventus Therapeutics.
- What does Brendan Bulik-Sullivan invest in?
- Brendan Bulik-Sullivan invests in AI & Machine Learning, Biotech.
- What check size does Brendan Bulik-Sullivan write?
- Brendan Bulik-Sullivan typically writes checks of $250K – $50M.
- What boards does Brendan Bulik-Sullivan sit on?
- Brendan Bulik-Sullivan holds tracked board seats at Santa Ana Bio, Ventus Therapeutics.
- What companies has Brendan Bulik-Sullivan invested in?
- Investments tracked here include Comanche Biopharma.
- Where did Brendan Bulik-Sullivan go to school?
- Brendan Bulik-Sullivan studied at University of California, Berkeley (Bachelor of Arts (B.A.), Mathematics); Vrije Universiteit Amsterdam (VU Amsterdam) (Doctor of Philosophy (PhD), Statistical Genetics).
- Does Brendan Bulik-Sullivan lead rounds?
- Yes — Brendan Bulik-Sullivan has led 1 tracked investment.
Same school
Also attended University of California, Berkeley1,361
Byron DeeterPartner at Bessemer Venture PartnersSteve WozniakCo-founder of AppleTony XuCo-founder & CEO of DoorDashAravind SrinivasCo-founder & CEO of Perplexity AIAli GhodsiCo-founder & CEO of DatabricksRyan PetersenFounder & CEO of Flexport
+ 1,355 more
Also attended Vrije Universiteit Amsterdam (VU Amsterdam)145
Kyang YungInvestor at DaphniJohann FriederichAssociate at Notion CapitalTies KlinkhamerJunior Associate at Keen Venture PartnersProf. Dr. Jan Peter BalkenendeVoorzitter at NoaberIrene KrijgsmanProgramma manager at NoaberLidwi van OsProgram & Office Support Officer at Noaber
+ 139 more